Embryo quality evaluation in Intra Cytoplasmic Sperm Injection (ICSI) cycles with Fertimorph system FRESH-PEF197-en Embryo quality evaluation in Intra Cytoplasmic Sperm Injection (ICSI) cycles with Fertimorph system QUALIMORPH FRESH-PEF197-en 197 FRESH-PEF197 Philippe NIEZ FERRING SAS Epidemiology France Portal (PEF) FERRING SAS null Philippe;NIEZ In Vitro Fertilization (IVF) FertiMORPH system embryo quality Intra Cytoplasmic Sperm Injection ICSI Gynaecology and obstetrics Contact with health services for medically assisted reproduction Healthcare system determinants: Use of care Healthcare system determinants Evaluate the concordance between the embryo quality appreciated by the biologist according to his normal technique and according to the Fertimorph system null France Individuals Patients population Female Young Adult (19 to 24 years) Adult (25 to 44 years) Embryos coming from couples having the following characteristics: -Criteria linked to the woman: woman with normal response, all infertility etiologies, aged up to 36 years, maximum of one prior assisted reproduction technique (ART) cycle, current ART cycle with ICSI with ejaculated or frozen sperm, normal ovarian reserve (evaluated via hormone assays and where applicable by an antral follicle count), with a normal uterus and without hydrosalpinx. -Criteria linked to the spouse: diagnosed male infertility, where applicable normal male karyotype, -Criteria linked to the studied attempt: at least 5 mature (MII) ovocytes retrieved, maximum of two embryos transferred. Clinical data Biological data Others One-time cross-sectional study Other Through organizations (health services or institutions schools businesses etc.) < 500 individuals Converting or copying information into a structured record Interview with the participant (including clinical) Observational Study Observational Study 130 Completed study To be defined Access on specific project only